Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Return on Sales (2016 - 2025)

Historic Return on Sales for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to 0.21%.

  • Dexcom's Return on Sales rose 800.0% to 0.21% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.18%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.18% for FY2025, which is 400.0% up from last year.
  • As of Q4 2025, Dexcom's Return on Sales stood at 0.21%, which was up 800.0% from 0.23% recorded in Q3 2025.
  • Over the past 5 years, Dexcom's Return on Sales peaked at 0.25% during Q4 2023, and registered a low of 0.01% during Q4 2021.
  • In the last 5 years, Dexcom's Return on Sales had a median value of 0.13% in 2023 and averaged 0.13%.
  • As far as peak fluctuations go, Dexcom's Return on Sales plummeted by -7300bps in 2021, and later surged by 1400bps in 2023.
  • Quarter analysis of 5 years shows Dexcom's Return on Sales stood at 0.01% in 2021, then surged by 1583bps to 0.11% in 2022, then skyrocketed by 120bps to 0.25% in 2023, then plummeted by -45bps to 0.14% in 2024, then skyrocketed by 56bps to 0.21% in 2025.
  • Its last three reported values are 0.21% in Q4 2025, 0.23% for Q3 2025, and 0.16% during Q2 2025.